Search - tctmd.com

Displaying 881 - 900 of 1094

Sort: Relevancy | Date

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2013

Jason Kahn

January 27, 2014

News Daily News

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

L.A. McKeown

January 27, 2014

News Daily News

Meta Análisis: Buen Perfil Hemorrágico con Dabigatran comparado con Warfarina en el Tratamiento de TEV y FA

L.A. McKeown

January 27, 2014

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

News Daily News

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

January 01, 2014

News Daily News

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

Yael L. Maxwell

January 01, 2014

News Daily News

初期研究显示利伐沙班拮抗剂安全、有效

December 30, 2013

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

News Daily News

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

December 05, 2013

News Daily News

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

November 26, 2013

News Industry News

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

Advertisement

Apixaban es Rentable comparado con Warfarina o Aspirina

TCTMD’s Top 10 Most Popular News Stories for 2013

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

Meta Análisis: Buen Perfil Hemorrágico con Dabigatran comparado con Warfarina en el Tratamiento de TEV y FA

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Meta Análisis: Comparados con la Warfarina los Nuevos Anticoagulantes Reducen a la Mitad las Hemorragias Intracraneales

Eficacia Similar y Menos Hemorragias con Dabigatran que con Warfarina en Pacientes TEV

初期研究显示利伐沙班拮抗剂安全、有效

Rivaroxaban Antidote Appears Safe, Effective in Early Study

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

Warfarin Offers Poor Protection Against Radial Occlusion After Transradial Angiography

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content